Abstract

INTRAUMBILICAL OXYTOCIN FOR MANAGEMENT OF RETAINED PLACENTA 2019

Dr. Ruwaida Hamza Salih*, Dr. Faeza Abadi Zamil AL. Badi, Dr. Fatimah Mohammad Ali Al. Momen

ABSTRACT

Objective: The purposeo f the study was to investigatet he removal of a retainedp lacenta. Method: O xytocin was injected into the vein of the umbilical cord. A total of 109 patients with retention of the placenta were randomized into two groups. Active management of the third stage of labor was carried out by giving oxytocin 5 IU intravenously and ergometrinem aleate 0.2 mg intramuscularlya fter delivery of the fetus. Group 1, which comprised6 8 patients,wa allocated to receive 50 IU oxytocin diluted in 10 ml 0.9% sodium chloride solution, and the 41 patients in group 2 were given 20 ml plasma expander (dextran 70) into the umbilical vein. Results: Forty-nine cases (7 2%) in the oxytocin group and 22 cases (54%) in the dextran 70 group required manual removal of the retained placenta. No significant differences were found between group 1 (oxytocin) and group 2 (dextran 70). Conclusion: Our results indicate that intraumbilical vein injection of oxytocin is not effective for removal of a retained placenta.

Keywords: Oxytocin; Retained placenta.